Quantinuum Claims Industry-Leading Error Correction, Accelerates Path to Reliable Quantum Computing
New error-correction result of 99.9995% fidelity puts Quantinuum closer to commercial fault-tolerant quantum computers by 2029.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
New error-correction result of 99.9995% fidelity puts Quantinuum closer to commercial fault-tolerant quantum computers by 2029.
Cleveland-Cliffs delivered its strongest quarter in three years with $612M adjusted EBITDA and guided for more than $4B in 2027, lifting the stock.
Deal backed by major shareholder, targets Blue Ops maritime growth.
JPMorgan upgraded Intel to Neutral from Underweight with an $85 target after a 36% pullback from its June peak, citing improved execution.
Two biotech IPOs and an AI infrastructure stock rose sharply on their early trading days even as the Nasdaq tumbled on broader tech weakness.